Fig. 6.
Elevated IL-6R expression delineates a subset of TIGIT− mTregs with increased expression of the canonical Th17 markers CD161 and CCR6. (A) Gating strategy to delineate IL-6R−/int (depicted in green) and IL-6Rhi (depicted in red) TIGIT− mTregs. (B) Data shown depict the frequencies of the Th17 markers CD161 (N = 23) and CCR6 (N = 12) in IL-6R−/int and IL-6Rhi mTregs, obtained by flow cytometry in freshly isolated PBMCs from healthy donors. P values were calculated using a two-tailed paired non-parametric Wilcoxon signed rank test.